CLINICAL_TRIALS
withdrawal
· 2024-09-25
Clinical Trial Update: Continuous Ambulatory Monitoring to Predict Elevated Risk of Infection in Children With Lymphoblastic Leukemia Undergoing Induction Chemotherapy (CAMPER-ALL)
Summary
A clinical trial investigating continuous ambulatory monitoring to predict infection risk in children with Acute Lymphoblastic Leukemia undergoing induction che…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: St. Jude Children's Research Hospital | Conditions: Acute Lymphoblastic Leukemia | Status: WITHDRAWN